AFLD 2007 FSGT vs Respondent M17

8 Mar 2007

Facts
The French Federation of Workers and Amateurs in sports (Fédération Sportive et Gymnique du Travail (FSGT) charges respondent M17 for a violation of the Anti-Doping Rules. During a cycling contest on May 27, 2006, a sample was taken for doping test purposes. The analysis showed the presence of a prednisone and prednisolone which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had used two pharmaceutical products for which he thinks that those ingredients are responsible for the positive test. However one of these products is known for an beta-2 Agonists which was not detected. He was using these products to treat allergies as well as a a persistent obstructive syndrome. However considering the fact that the products he describes are not known for containing glucocorticosteroids, and the way he uses the product as auto medication, he has no justifiable use of these products.

Decision
1. The sanction is a period of ineligibility of one year in which respondent can't take part in competition or manifestations organized or authorized by sport federations.
2. The present decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2007 FFC vs Respondent M16

8 Feb 2007

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M16 for a violation of the Anti-Doping Rules. During a cycling event on June 4, 2006, a sample was taken for doping control purposes. Analysis of the sample showed an abnormally high testosterone on epitestosterone level, an additional radio spectrometric analysis showed the presence of testosterone with exogenous origin. Exogenous testosterone is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent appealed on September 30, 2006, against the decision, dated September 27, 2006, by the disciplinary committee of the FFC. However his claiming about an incorrect procedure during the doping control are not recognized. Before the match he had had an injection against a persistence of muscle disorders in the left leg. He has a medical certificate proving the treatment, however he hadn't mentioned this on the doping control form because he thought the traces of this had already disappeared.

Decision
1. The sanction is period of ineligibility of two years in which the respondent can't take part in competition or manifestations organized or authorized by sport federations.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2007 FFN vs Respondent M15

8 Feb 2007

Facts
The French Swimming Federation (Fédération Française de Natation, FFN) charges respondent M15 for a violation of the Anti-Doping Rules. During a swimming event on June 17, 2006, a sample was taken for doping test purposes. Analysis of the sample showed an abnormally high testosterone on epitestosterone level, a additional radio spectrometric analysis showed the presence of testosterone with exogenous origin. Exogenous testosterone is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent didn't provide any information during the procedure and didn't attend the hearing.

Decision
1. The sanction is a period of ineligibility of two years in which respondent can't take part in competition or manifestations organized by French sport federations which is the same sanction as the disciplinary committee of the had pronounced on October 25, 2006.
2. The period of ineligibility will be reduced by the period already served in voluntary suspension.
3. The decision start on the date of notification.
4. The decision will be published and sent to the parties involved.

AFLD 2007 FFA vs Respondent M14

8 Feb 2007

Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M14 for a violation of the Anti-Doping Rules. During an athletics event on September 24, 2006, a sample was taken for doping test purposes. The analysis of the sample showed the presence of metabolites of adrafinil and modafinil these substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had used a pharmaceutical product to treat tiredness. He has a certificate for the use of it as a treatment, but a second certificate indicates that the physician hadn't renewed the use of this medication.

Decision
1. The sanction is a period of ineligibility of twelve months in which respondent can't take part in competition or sport manifestations organized by sport federations.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2007 FFHMFAC vs Respondent M13

25 Jan 2007

Facts
The French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme, FFHMFAC) charges respondent M13 for a violation of the Anti-Doping Rules. During a contest on May 20, 2006, a sample was taken for doping test purposes. The sample showed the presence of a metabolite of nandrolone and a metabolite of Stanozolol. Nandrolone and stanozolol are prohibited according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent didn't provide any information about how the prohibited substance had entered his body.

Decision
1. The sanction is a period of ineligibility of three years in which respondent can't take part in competition or manifestations organized or authorized by sport federations.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2007 FFHMFAC vs Respondent M12

25 Jan 2007

Facts
The French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme, FFHMFAC) charges respondent M12 for a violation of the Anti-Doping Rules. During a contest on May 13, 2006, a sample was taken for doping test purposes. The samples showed the presence of althiazide, canrenone, bumetanide, clenbuterol and a metabolite of mesterolone. These substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had mentioned the use of two pharmaceurtical products, one of these products contained a stimulant which was not detected during the doping control. He used it because of problems with his veins, for which he has medical certificates. However only the use of althiazide is consistent for a therapeutic justification.

Decision
1. The sanction is a period of ineligibility of three years in which respondent can't take part in competition or manifestations organized or authorized by sport federations.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2007 FSGT vs Respondent M11

25 Jan 2007

Facts
The French Federation of Workers and Amateurs in sports (Fédération Sportive et Gymnique du Travail (FSGT) charges respondent M11 for a violation of the Anti-Doping Rules. During a cycling contest on July 12, 2006, a sample was taken for doping test purposes. The analysis showed the presence of a metabolite of budesonide. Budesonide is prohibited according the World Anti-Doping Agency (WADA) prohibited list and regarded as a specified substance.

History
The respondent used medication for problems with breathing, this medication contained the prohibited substance. He has transmitted the results of tests realized by a pulmonologist. However he had failed to mention the used product on the doping control form.

Decision
1. The sanction is a period of ineligibility of one year in which respondent can't take part in competition or manifestations organized or authorized by sport federations.
2. The present decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.

IBU 2014 IBU vs Evi Sachenbacher-Stehle

14 Jul 2014

Related cases:
IOC 2014 IOC vs Evi Sachenbacher-Stehle
February 21, 2014
CAS OG_06_04 Deutscher Skiverband & Evi Sachenbacher vs FIS
February 12, 2006
CAS 2014_A_3685 Evi Sachenbacher-Stehle vs IBU
November 14, 2014

Ms. Evi Sachenbacher-Stehle is a German Athlete competing in Women’s Biathlon events at the Sochi 2014 Olympic Winter Games.

On 20 February 2014 the International Olympic Committee (IOC) reported an anti-doping rule violation against the Athlete after her A and B samples tested positive for the prohibited substance methylhexaneamine (dimethylpentylamine).

Therefore on 21 February 2014 the IOC Disciplinary Commission decides that the Athlete is disqualified from the biathlon events and excluded from the Sochi 2014 Olympic Winter Games.

Due to the IOC sanction the International Biathlon Union (IBU) started proceedings against the Athlete. After notification by IBU the Athlete filed a statement in her defence and was heard for the IBU Anti-Doping Hearing Panel (ADHP)

The Athlete stated she used the product Shisandrea, as recommended by her nutritional advisor, and didn’t know it contained a prohibited substance. She and her advisor researched the product before using and she had no intention to enhance her performance.

Without mitigating circumstances the ADHP decides on 14 July 2014 to impose a 2 year period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 17 February 2014.

IBU 2014 IBU vs Irina Starykh

14 Jul 2014

Related case:
IBU 2015 IBU vs Irina Starykh
June 30, 2015

In January 2014 the International Biathlon Union (IBU) has reported an anti-doping rule violation against the Athlete Irina Starykh after her A and B samples tested positive for the prohibited substance recombinant human erythropoetin (rhEPO). After notification a provisional suspension was ordered.

The Athlete gave a prompt admission, denied the intentional use and waived het right to be heard for the IBU Anti-Doping Hearing Panel.
She submitted that the probable source of the positive test is the drug Laennec used to improve her cosmetic appearance and not for the purpose to enhance her sports performance.

Without exceptional circumstances the IBU Anti-Doping Hearing Panel decides on 14 July 2014 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 23 December 2013.

AFLD 2007 FFESSM vs Respondent M10

25 Jan 2007

Facts
The French Federation of Undersea Studies and Sports (Fédération Française d'Etudes et de Sports Sous Marins, FFESSM) charges respondent M10 for a violation of the Anti-Doping Rules. During an event on March 11, 2006, respondent didn't attend the doping control.

History
Respondent was summoned to attend the doping control but he
made an agreement not to attend the control. He had just beaten a record. He didn't provide any explanation for not attending the doping control.

Decision
1. The sanction is a period of ineligibility of one month in which respondent can't take part in competition or manifestations organized or authorized by the FFESSM.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin